Robert Schrèk

2.4k total citations
92 papers, 1.4k citations indexed

About

Robert Schrèk is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Robert Schrèk has authored 92 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 18 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Robert Schrèk's work include Chronic Lymphocytic Leukemia Research (23 papers), Acute Lymphoblastic Leukemia research (13 papers) and Lymphoma Diagnosis and Treatment (12 papers). Robert Schrèk is often cited by papers focused on Chronic Lymphocytic Leukemia Research (23 papers), Acute Lymphoblastic Leukemia research (13 papers) and Lymphoma Diagnosis and Treatment (12 papers). Robert Schrèk collaborates with scholars based in United States and Switzerland. Robert Schrèk's co-authors include William J. Donnelly, Yale Rabinowitz, William C. Dolowy, Frederick W. Preston, Lyle A. Baker, Zelma Molnar, Irving A. Friedman, Clement C.S. Hsu, Gerald E. Marti and Stefania Stefani and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Robert Schrèk

87 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Schrèk United States	21	410	390	351	244	243	92	1.4k
Edwin E. Osgood United States	20	178 0.4×	426 1.1×	259 0.7×	81 0.3×	138 0.6×	43	1.3k
F Gavosto Italy	24	339 0.8×	365 0.9×	402 1.1×	127 0.5×	401 1.7×	112	1.6k
Robert J. Marder United States	16	298 0.7×	210 0.5×	223 0.6×	431 1.8×	332 1.4×	38	1.3k
F. Schmalzl Austria	18	376 0.9×	247 0.6×	231 0.7×	68 0.3×	134 0.6×	85	1.1k
Niels Ebbe Hansen Denmark	24	525 1.3×	211 0.5×	422 1.2×	140 0.6×	302 1.2×	50	1.6k
Leonhard Korngold United States	21	382 0.9×	177 0.5×	454 1.3×	87 0.4×	160 0.7×	69	1.6k
P M Lydyard United Kingdom	20	1000 2.4×	163 0.4×	300 0.9×	131 0.5×	181 0.7×	49	1.6k
Manuel E. Kaplan United States	25	473 1.2×	944 2.4×	543 1.5×	562 2.3×	387 1.6×	53	2.3k
George B. Naff United States	15	718 1.8×	674 1.7×	267 0.8×	109 0.4×	103 0.4×	37	1.6k
Anna‐Brita Laurell Sweden	23	702 1.7×	510 1.3×	236 0.7×	132 0.5×	112 0.5×	78	1.8k

Countries citing papers authored by Robert Schrèk

Since Specialization

Citations

This map shows the geographic impact of Robert Schrèk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schrèk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schrèk more than expected).

Fields of papers citing papers by Robert Schrèk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Schrèk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schrèk. The network helps show where Robert Schrèk may publish in the future.

Co-authorship network of co-authors of Robert Schrèk

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Schrèk. A scholar is included among the top collaborators of Robert Schrèk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Schrèk. Robert Schrèk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schrèk, Robert. (1991). Intractable chronic lymphocytic leukemia and interferon. Medical Hypotheses. 35(3). 182–183. 1 indexed citations

Schrèk, Robert. (1990). Differences between responsive and intractable chronic lymphocytic leukemia. Medical Hypotheses. 31(2). 81–82. 5 indexed citations

Schrèk, Robert, William R. Best, & Stefano De Stefani. (1988). Relationship between in vitro and in vivo Radiosensitivity of Lymphocytes in Chronic Lymphocytic Leukemia. Acta Haematologica. 80(3). 129–133. 6 indexed citations

Schrèk, Robert, et al.. (1980). Two types of interphase death of lymphocytes exposed to temperatures of 37--45 degrees C.. PubMed. 82(1). 162–70. 24 indexed citations

Schrèk, Robert, et al.. (1976). Inhibition by Ionophore A23187 of the Cytotoxicity of Vincristine, Colchicine and X-Rays to Leukemic Lymphocytes. Oncology. 33(3). 132–135. 9 indexed citations

Schrèk, Robert. (1975). Sensitivity of leukaemic lymphocytes to microtubular reagents.. PubMed. 56(3). 280–5. 4 indexed citations

Schrèk, Robert, et al.. (1973). Effect of Asparagine and Glutamine Deficiency on Normal and Leukemic Cells 2. JNCI Journal of the National Cancer Institute. 51(4). 1103–1107. 22 indexed citations

Schrèk, Robert, John S. Holcenberg, Joseph Roberts, & William C. Dolowy. (1971). In vitro Cytocidal Effect of L-Glutaminase on Leukaemic Lymphocytes. Nature. 232(5308). 265–265. 13 indexed citations

Schrèk, Robert, et al.. (1966). SPECIES DIFFERENCES IN THE IN VITRO SENSITIVITY OF LYMPHOCYTES TO PREDNISOLONE AND X-RAYS. Journal of Pharmacology and Experimental Therapeutics. 152(3). 525–528. 15 indexed citations

10.

Schrèk, Robert. (1966). Cytology of viable blood cells of tissue mast cell leukemia. Two cases. Cancer. 19(1). 134–136. 2 indexed citations

11.

Schrèk, Robert, et al.. (1964). CYTOTOXIC EFFECTS OF X‐RAYS ON NORMAL AND LEUKEMIC LYMPHOCYTES*. Annals of the New York Academy of Sciences. 113(2). 1033–1042. 8 indexed citations

12.

Schrèk, Robert. (1961). Cytotoxicity of Adrenal Cortex Hormones on Normal and Malignant Lymphocytes of Man and Rat. Experimental Biology and Medicine. 108(2). 328–332. 25 indexed citations

13.

Schrèk, Robert. (1958). In vitro sensitivity of normal human lymphocytes to x-rays and radiomimetic agents.. PubMed. 51(6). 904–15. 18 indexed citations

14.

Schrèk, Robert, et al.. (1958). Antitumor effects of homologous immune serum, immune lymphocytes and nitrogen mustard against a rat lymphoma.. PubMed. 9. 583–7. 1 indexed citations

15.

Schrèk, Robert. (1956). Fifty Per Cent Survival Time as a Measure of Prognosis in Cancer. American Journal of Clinical Pathology. 26(2). 172–174. 4 indexed citations

16.

Schrèk, Robert & Frederick W. Preston. (1956). Toxicity of Homologous Immune Serum to a Transplantable Tumor: Studies Using Phase Microscopy and Cinemicrography<xref ref-type="fn" rid="fn1">2</xref>. JNCI Journal of the National Cancer Institute. 16(4). 1021–45. 21 indexed citations

17.

Schrèk, Robert, et al.. (1955). An antitumor factor in the blood of tumor immune rats.. PubMed. 5. 631–7. 1 indexed citations

18.

Schrèk, Robert. (1955). Statistics in Research. Basic Concepts and Techniques for Research Workers. American Journal of Clinical Pathology. 25(8). 951.1–951. 11 indexed citations

19.

Schrèk, Robert, et al.. (1953). Unstained cell counts as a method of evaluating cancerocidal agents.. PubMed. 42(2). 326–34. 4 indexed citations

20.

Schrèk, Robert. (1951). Color Test to Measure the Toxicity of Adrenal Cortex Hormones to Lymphocytes.. Experimental Biology and Medicine. 76(3). 557–559. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact